supported by grants from the National Natural Science Foundation of China(No.81270255 to L-SW)
We aimed to investigate the effectiveness and safety of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin Ⅱ receptor blockers (ARBs) on preventing atrial fibrillation in essential hypertensive patie...
Objective The purpose of this review was to delineate our current knowledge of the close relationship between the abundance of epicardial adipose tissue (EAT) and the risk of all major cardiovascular disease, especi...
Background Many recipients of implantable cardiac electronic devices have atrial fibrillation (AF) occurrences after device implantation, even if there is no previous history of AF, and some of the episodes are asym...
Background Circumferential pulmonary vein isolation (CPVI), as the basal ablation strategy for treating atrial fibrillation (AF), not only isolates the connection between the left atrium (LA) and the pulmonary v...
Atrial fibrillation (AF) is the most frequent arrhythmia .whose incidence increases with age. At presentabout 1%-2% of the European population suffer from AF. Presumably about 25% of the population between 40 and 50...
Dextrocardia is a rare anomaly where the heart is located on the right side of the chest instead of the normal left side. Ablation of atrial fibrillation (AF) with such an inverted anatomy may be challenging for the...
Ablation of persistent atrial fibrillation is still a challenge for the ablationist. Extensive ablation is required under some conditions and could lead to some unintended complications. Here we report a case of atriu...
Atrial fibrillation (AF) is one of the most common .arrhythmias in clinical practice. AF results in electrophysiological alterations which involve increased atrial effective refractory period and atrial effective re...